Scholars Central

Conference abstractPublished 3 Jul 2017

Gonadotropin releasing hormone agonists (GnRH-A) induce direct apoptotic effects upon the human prostate cancer DU-145 cells: Potential avenue for treatment

Authors: Zvi Naor

Tel Aviv University, Israel

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

GnRH is the primary and a key hormone which controls the reproductive system in all vertebrates. GnRH binds to its cognate receptor (GnRHR) in pituitary gonadotropes to regulate the synthesis and secretion of the gonadotropins: Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). LH and FSH in turn control gametogenesis and sex hormone production in the gonads. GnRHRs are present not only in pituitary gonadotropes but also in some sex-hormone dependent cancers, including prostate cancer. Prostate cancer which is also known as Carcinoma of the Prostate (CaP) is the second death causing cancer in the western world. While GnRH secretion in a pulsatile manner regulates normal reproductive functions, application of GnRH agonists (GnRH-A) or antagonists in a continuous manner disrupts this regulation. As a result, the continuous application of GnRH-A causes desensitization of the GnRHR in the pituitary, termination of production and secretion of LH and FSH which in turn causes reduction in testosterone secretion, known as Chemical Castration. This is the basis for the clinical use of GnRH analogs in prostate cancer. However, in later stages, CaP may become hormoneindependent, therefore, treatment with GnRH-A in a continuous manner is not beneficial for these cancers. Hence, a novel potential treatment for hormone-independent CaP is required and so it was very important to us to investigate this issue and explore a potential beneficial treatment. Indeed, direct apoptotic effects of GnRH-A upon hormone-independent CaP cells (DU-145) has been described, but the magnitude of the effect was not sufficient and potentiation of the effect was required. In this presentation, we will describe our efforts to elucidate cross-talks between the GnRHR and other GPCRs with the basic aim to potentiate the apoptotic effect of GnRH-A. Since there is no cure to advanced hormone resistant CaP, our work may open a new vista for the development of a combination therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Zvi Naor”